ロード中...
Low-density lipoprotein cholesterol lowering treatment: the current approach
In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of low-density lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase inhibitor...
保存先:
| 出版年: | Lipids Health Dis |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201678/ https://ncbi.nlm.nih.gov/pubmed/32375792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-020-01275-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|